New Delhi, 3 July 2024: The popular weight loss and diabetes drug Tirzepatide  — marketed as Mounjaro and Zepbound in the US —  is likely to hit the markets in India though there has been no confirmation on its launch date.

 

The drug ha......
View Details

Related News

• Illegal Medical Store Raided, Huge Cache Of Drugs Seized In Sardarpur (07-07-2024)

---

• Antibiotic use annually rising about 8% in outpatients, 11% in indoor patients: Experts (07-07-2024)

---

• CDSCO issues guidance document on export NOC for unapproved, banned and new drugs (06-07-2024)

---

• First case under BNS in drug abuse was filed against an illegal drug manufacturer in Telangana (06-07-2024)

---

• Unusually Large Injection Ampoules Found with Quacks Raise Concerns Among Medical Experts (06-07-2024)

---

• Ministry has yet not decided on its plan for cervical cancer vaccination campaign: Report (06-07-2024)

---

• 73rd IPC inaugurated in Hyderabad, with emphasis on innovation and healthcare (06-07-2024)

---

• No anticipatory bail to man who held illegal blood donation camp (05-07-2024)

---

• YEIDA set to build flatted factories for medical devices soon (05-07-2024)

---

• Medanta Hospital Secures Patent for Groundbreaking Cervical Cancer Treatment Device (05-07-2024)

---